Article
Nuclear transcription factor CDX2 inhibits gastric cancer‑cell growth and reverses epithelial‑to‑mesenchymal transition in vitro and in vivo.
Molecular medicine reports - 1 Oct 2015
Zhang Jian-Feng, Qu Li-Shuai, Qian Xue-Fen, Xia Bei-Lei, Mao Zhen-Biao, Chen Wei-Chang
Abstract excerpt
The epithelial‑to‑mesenchymal transition (EMT) has been noted as a critical event in the early step of cancer metastasis. Recent studies showed that nuclear transcription factor caudal type homeobox transcription factor 2 (CDX2) is a prognostic factor, which acts as a marker of good outcome in gastric cancer (GC) patients. However, the association between CDX2 expression and EMT has remained to be fully...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
